PERCEPTIVE ADVISORS LLC
CIK
1224962
Location
NEW YORK, NY
Portfolio Value
Large
$45,197,334,793
Diversification
Highly concentrated
Filing Date
Global Rank
#149
/ 7,976
▲ 980
Top Industry
Biotechnology
98.7%
3Y Alpha vs SPY
-15.7%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
23 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+16.1%
SPY
+76.5%
Annualised alpha
-15.7%
Max drawdown
−46.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
82 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
93.6%
+85.4 pts
Top 5
95.2%
+61.7 pts
Top 10
96.4%
+46.7 pts
HHI
8,771
Highly concentrated+8,412
Portfolio Trend
23 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.9% | $45,171,868,000 |
| Unclassified | 0.1% | $25,466,793 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals, Inc. | +416,686,670 | 419,104,969 | $42,325,410,819 | |
| ROIV | Roivant Sciences Ltd. | +4,036,996 | 7,368,461 | $111,484,814 | |
| TVTX | Travere Therapeutics, Inc. | +2,960,363 | 3,794,615 | $90,691,298 | |
| CTMX | CytomX Therapeutics, Inc. | +2,686,539 | 9,680,185 | $30,879,790 | |
| CNTA | Centessa Pharmaceuticals plc | +1,953,967 | 3,100,902 | $75,196,873 | |
| AQST | Aquestive Therapeutics, Inc. | +1,569,679 | 3,760,099 | $21,018,953 | |
| CELC | Celcuity Inc. | +1,323,111 | 2,956,319 | $146,042,158 | |
| ALDX | Aldeyra Therapeutics, Inc. | +1,170,680 | 5,222,311 | $27,260,463 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +1,050,000 | 8,952,365 | $121,662,640 | |
| VRDN | Viridian Therapeutics, Inc.DE | +1,014,893 | 1,462,400 | $31,558,592 | |
| ZYME | Zymeworks Inc. | +815,389 | 2,090,663 | $35,708,524 | |
| PRAX | Praxis Precision Medicines, Inc. | +811,633 | 1,564,554 | $82,921,362 | |
| OBIO | Orchestra BioMed Holdings, Inc. | +700,000 | 5,292,556 | $13,125,538 | |
| INBX | Inhibrx Biosciences, Inc. | +349,815 | 1,327,707 | $44,717,171 | |
| NRIX | Nurix Therapeutics, Inc. | +319,164 | 1,416,149 | $13,085,216 | |
| NBIX | Neurocrine Biosciences Inc | +195,000 | 450,050 | $63,178,019 | |
| PEN | Penumbra Inc | +187,750 | 220,547 | $55,868,966 | |
| NUVL | Nuvalent, Inc. | +187,156 | 1,562,336 | $135,110,817 | |
| APGE | Apogee Therapeutics, Inc. | +169,841 | 1,351,989 | $53,714,522 | |
| ASND | Ascendis Pharma A/S | +124,615 | 1,088,501 | $216,404,883 | |
| RGEN | Repligen Corp | +104,428 | 270,428 | $36,148,110 | |
| INSM | INSMED Inc | +51,878 | 702,130 | $101,113,741 | |
| BSX | Boston Scientific Corp | +30,000 | 310,000 | $30,265,300 | |
| DRUG | Bright Minds Biosciences Inc. | +28,600 | 449,290 | $27,253,931 | |
| CTNM | Contineum Therapeutics, Inc. | +15,106 | 714,592 | $8,396,456 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
18 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | −1,706,946 | 540,444 | $6,836,616 | |
| BBNX | Beta Bionics, Inc. | −1,315,664 | 277,944 | $5,522,747 | |
| FOLD | AMICUS THERAPEUTICS, INC. | −1,041,979 | 6,370,851 | $50,202,305 | |
| EWTX | Edgewise Therapeutics, Inc. | −844,055 | 3,795,894 | $61,569,400 | |
| AORT | Artivion, Inc. | −773,703 | 2,020,000 | $85,526,800 | |
| IMVT | Immunovant, Inc. | −550,000 | 1,587,890 | $25,596,786 | |
| SYRE | Spyre Therapeutics, Inc. | −300,000 | 1,229,445 | $20,605,498 | |
| VKTX | Viking Therapeutics, Inc. | −275,103 | 105,597 | $2,775,089 | |
| ADMA | Adma Biologics, Inc. | −150,000 | 1,153,468 | $16,909,840 | |
| SLDB | Solid Biosciences Inc. | −73,107 | 11,833,539 | $73,012,935 | |
| AXSM | Axsome Therapeutics, Inc. | −49,634 | 148,900 | $18,083,905 | |
| PTGX | Protagonist Therapeutics, Inc | −44,314 | 1,030,134 | $68,431,801 | |
| KYMR | Kymera Therapeutics, Inc. | −40,310 | 169,796 | $9,610,453 | |
| SION | Sionna Therapeutics, Inc. | −36,947 | 1,179,098 | $34,677,272 | |
| OMDA | Omada Health, Inc. | −30,000 | 2,396,330 | $52,982,856 | |
| LYRA | Lyra Therapeutics, Inc. | −25,768 | 229,382 | $1,496,946 | |
| IKT | Inhibikase Therapeutics, Inc. | −10,725 | 5,421,568 | $8,782,940 | |
| ACLX | Arcellx, Inc. | −9,647 | 2,468,353 | $202,651,781 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
20 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ABVX | Abivax S.A. | 388,608 | $32,992,819 | |
| EXAS | EXACT SCIENCES CORP | 465,487 | $25,466,793 | |
| PVLA | Palvella Therapeutics, Inc. | 395,093 | $24,768,380 | |
| ORKA | Oruka Therapeutics, Inc. | 1,268,021 | $24,384,043 | |
| IRTC | iRhythm Holdings, Inc. | 123,000 | $21,154,770 | |
| ENGN | enGene Therapeutics Inc. | 2,097,236 | $14,324,121 | |
| RAPP | Rapport Therapeutics, Inc. | 403,923 | $11,996,513 | |
| KOD | Kodiak Sciences Inc. | 634,577 | $10,388,025 | |
| GOSS | Gossamer Bio, Inc. | 3,812,797 | $10,027,656 | |
| TEM | Tempus AI, Inc. | 85,000 | $6,860,350 | |
| KRYS | Krystal Biotech, Inc. | 35,000 | $6,178,550 | |
| HTFL | Heartflow, Inc. | 150,000 | $5,049,000 | |
| PEPG | PepGen Inc. | 829,870 | $3,833,999 | |
| BLTE | Belite Bio, Inc | 49,788 | $3,684,312 | |
| PYXS | Pyxis Oncology, Inc. | 1,178,307 | $2,615,841 | |
| LONA | LeonaBio, Inc. | 540,296 | $2,236,825 | |
| SPRY | ARS Pharmaceuticals, Inc. | 200,000 | $2,010,000 | |
| QURE | uniQure N.V. | 20,000 | $1,167,400 | |
| BDSX | Biodesix Inc | 108,694 | $820,639 | |
| ANRO | Alto Neuroscience, Inc. | 155,366 | $624,571 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 430,439 | $36,062,179 | |
| EOLS | Evolus, Inc. | 2,474,843 | $22,793,304 | |
| PODD | Insulet Corp | 60,387 | $18,972,387 | |
| CRL | Charles River Laboratories International, Inc. | 100,000 | $15,173,000 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 270,000 | $9,817,200 | |
| CAPR | Capricor Therapeutics, Inc. | 750,000 | $7,447,500 | |
| GMED | Globus Medical Inc | 88,500 | $5,223,270 | |
| FBRX | Forte Biosciences, Inc. | 68,192 | $881,722 | |
| KALA | KALA BIO, Inc. | 55,227 | $262,880 | |
| No positions match the current search. | ||||
82 positions ·
$45,197,334,793 total
· as of Sep 30, 2025
Showing 1–50
of 82 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 419,104,969 | $42,325,410,819 | 93.65% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 1,088,501 | $216,404,883 | 0.48% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
Reduced | 2,468,353 | $202,651,781 | 0.45% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 2,956,319 | $146,042,158 | 0.32% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 1,562,336 | $135,110,817 | 0.30% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 8,952,365 | $121,662,640 | 0.27% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 7,368,461 | $111,484,814 | 0.25% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Held | 12,626,103 | $103,912,827 | 0.23% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 702,130 | $101,113,741 | 0.22% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 3,794,615 | $90,691,298 | 0.20% | |
| AORT |
Artivion, Inc.
Healthcare
|
Reduced | 2,020,000 | $85,526,800 | 0.19% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 1,564,554 | $82,921,362 | 0.18% | |
| IMTX |
Immatics N.V.
Healthcare
|
Held | 9,383,456 | $79,947,045 | 0.18% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 3,100,902 | $75,196,873 | 0.17% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Reduced | 11,833,539 | $73,012,935 | 0.16% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 1,030,134 | $68,431,801 | 0.15% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Added | 450,050 | $63,178,019 | 0.14% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 3,795,894 | $61,569,400 | 0.14% | |
| PEN |
Penumbra Inc
Healthcare
|
Added | 220,547 | $55,868,966 | 0.12% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 1,351,989 | $53,714,522 | 0.12% | |
| OMDA |
Omada Health, Inc.
Healthcare
|
Reduced | 2,396,330 | $52,982,856 | 0.12% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
Reduced | 6,370,851 | $50,202,305 | 0.11% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
Added | 1,327,707 | $44,717,171 | 0.10% | |
| RGEN |
Repligen Corp
Healthcare
|
Added | 270,428 | $36,148,110 | 0.08% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Added | 2,090,663 | $35,708,524 | 0.08% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Reduced | 1,179,098 | $34,677,272 | 0.08% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Held | 1,098,163 | $33,219,430 | 0.07% | |
| ABVX |
Abivax S.A.
Healthcare
|
NEW | 388,608 | $32,992,819 | 0.07% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Added | 1,462,400 | $31,558,592 | 0.07% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 9,680,185 | $30,879,790 | 0.07% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 310,000 | $30,265,300 | 0.07% | |
| ALDX |
Aldeyra Therapeutics, Inc.
Healthcare
|
Added | 5,222,311 | $27,260,463 | 0.06% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 449,290 | $27,253,931 | 0.06% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 1,587,890 | $25,596,786 | 0.06% | |
| EXAS |
EXACT SCIENCES CORP
|
NEW | 465,487 | $25,466,793 | 0.06% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
NEW | 395,093 | $24,768,380 | 0.05% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 1,268,021 | $24,384,043 | 0.05% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Added | 52,119 | $23,309,180 | 0.05% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
NEW | 123,000 | $21,154,770 | 0.05% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Added | 3,760,099 | $21,018,953 | 0.05% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 1,229,445 | $20,605,498 | 0.05% | |
| ADGM |
Adagio Medical Holdings, Inc.
Healthcare
|
Held | 9,876,576 | $19,160,557 | 0.04% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 148,900 | $18,083,905 | 0.04% | |
| ADMA |
Adma Biologics, Inc.
Healthcare
|
Reduced | 1,153,468 | $16,909,840 | 0.04% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
NEW | 2,097,236 | $14,324,121 | 0.03% | |
| OBIO |
Orchestra BioMed Holdings, Inc.
Healthcare
|
Added | 5,292,556 | $13,125,538 | 0.03% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 1,416,149 | $13,085,216 | 0.03% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
NEW | 403,923 | $11,996,513 | 0.03% | |
| OM |
Outset Medical, Inc.
Healthcare
|
Held | 833,333 | $11,766,661 | 0.03% | |
| NAUT |
Nautilus Biotechnology, Inc.
Healthcare
|
Held | 12,594,211 | $10,642,108 | 0.02% |